Alcista
$12.15
Precio del escenario
$9.780
+0.010 (+0.10%)Al cierre
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.
Core Laboratories Inc is currently a hold. The current price is $10.09, with a forward P/E ratio of 19.76, indicating that the stock is relatively valued in the market. However, the RSI is at 40.05, suggesting that the stock is nearing oversold territory, which could present a buying opportunity if momentum shifts. The main risk is the recent downgrade from BofA, which lowered the price target to $11, indicating potential downside.
Johnson Rice
$21
2026-08-13
Johnson Rice
2026-08-13
Precio objetivo
$21
BofA
$11
2026-07-15
BofA
2026-07-15
Precio objetivo
$11
Stifel
$12
2025-07-16
Stifel
2025-07-16
Precio objetivo
$12
Citi
$13
2025-05-13
Citi
2025-05-13
Precio objetivo
$13
Stifel
$13
2025-04-25
Stifel
2025-04-25
Precio objetivo
$13
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Core Laboratories Q2 2026 Earnings Call Insights

Core Laboratories Q2 2026 Earnings Call Insights

Core Laboratories Q2 Earnings Beat Expectations

Core Laboratories Declares Quarterly Dividend

Core Laboratories RSI Analysis Indicates Potential Buy Opportunity
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects. It operates in the Industrials sector (OIL & GAS FIELD SERVICES, NEC industry).
Core Laboratories Inc is currently a hold. The current price is $10.09, with a forward P/E ratio of 19.76, indicating that the stock is relatively valued in the market. However, the RSI is at 40.05, suggesting that the stock is nearing oversold territory, which could present a buying opportunity if momentum shifts. The main risk is the recent downgrade from BofA, which lowered the price target to $11, indicating potential downside.
18 analysts cover CLB: 10 rate it Buy, 8 Hold and 0 Sell. The average price target is 11.50.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.